Revista Espanola de Quimioterapia

Article	Citations
New variants of SARS-CoV-2	46
Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings	46
Pharmacological treatment of COVID-19: an opinion paper	41
Insights for COVID-19 in 2023	36
Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter?	29
Temporary hospitals in times of the COVID pandemic. An example and a practical view	29
Monkeypox in humans: a new outbreak	29
Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination	28
Utility of lateral flow tests in SARS-CoV-2 infection monitorization	23
Remdesivir, the antiviral hope against SARS-CoV-2	20
Real-life use of remdesivir in hospitalized patients with COVID-19	19
COVID-19: Impact on prescribing and antimicrobial resistance	17
The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up	17
Aspiration pneumonia	15
Post-COVID syndrome: A reflection and opinion paper	13
Potential biomarkers predictors of mortality in COVID-19 patients in the Emergency Department	12
Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting	11
COVID-19 in Spanish and immigrant patients in a sanitary district of Madrid	11
Dalbavancin	10
High level of medication regimen complexity index correlate with worse quality of life in people living with HIV	10
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences	9
Respiratory co-and superinfections in COVID-19	9
Vaccine against COVID-19	8
Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain	8
Booster or additional vaccination doses in patients vaccinated against COVID-19	8

Antimicrobial stewardship programs in emergency departments: how do we measure antimicrobial use? A systematic review	8
Scoping review of coronavirus case series (SARS-CoV, MERS-CoV and SARS-CoV-2) and their obstetric and neonatal results	8
Antiviral drugs against SARS-CoV-2	8
Experience with the use of siltuximab in patients with SARS-CoV-2 infection	7
Impact of the COVID-19 pandemic on the mental health of the general population and health care workers	7
Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections	7
Ceftazidime-avibactam	7
Cefiderocol	7
The Spanish flu and the fiction literature	7
Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study	7
Recommendations on the use of azole antifungals in hematology-oncology patients	6
New definitions of susceptibility categories EUCAST 2019: clinic application	6
Patients with non-tuberculous mycobacteria in respiratory samples: a 5-year epidemiological study	6
Immunity against SARS-CoV-2: walking to the vaccination	6
Emergency detection of HIV infection in patients consulting for conditions potentially related to occult infection: Initial results of the “Urgències VIHgila” program	6
Ceftolozane-tazobactam: When, how and why using it?	6
Evaluation of different genes in the RT-PCR detection of SARS-CoV-2 in respiratory samples and its evolution in infection	6
Sepsis Code: dodging mortality in a tertiary hospital	5
Current microbiological aspects of community respiratory infection beyond COVID-19	5
High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures	5
Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence	5
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-neg	5
Importance of blood cultures results: and special attention for applicants from the Emergency Department	5
Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability	5
Oral antibiotic treatment of exacerbation of COPD. Beyond COVID-19	5
Diagnostic accuracy of combining C-Reactive protein and Alvarado Score among 2-to-20-year-old patients with acute appendicitis suspected presenting to Emergency Departments	5
Impact of Spanish Public Health Measures on Emergency Visits and COVID- 19 diagnosed cases during the pandemic in Madrid	5
Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience	5
Ceftobiprole: a clinical view	5
COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome	5
Usefulness of monocyte distribution width (MDW) as a sepsis biomarker	5
Impact of hygienic and social distancing measures against SARS-CoV-2 on respiratory infections caused by other viruses	4
Clinical implications of the genus Mycoplasma	4
Infection and infectivity: Utility of rapid antigen tests for the diagnosis of COVID-19	4
Identificación de creencias y actitudes relacionadas con la desprescripción en pacientes VIH+ de edad avanzada: Proyecto ICARD	4
Trend in the use of topical ocular anti-infectives in a region of Spain between 2015 and 2019: a population-based registry study	4
Community-acquired pneumonia: selection of empirical treatment and sequential therapy. SARS-CoV-2 implications	4
High-dose trivalent influenza vaccine. Efficacy and effectiveness	4
Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies	4
Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients	4
SARS-CoV-2 infection presenting as acute acalculous cholecystitis	4
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection	4
Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outb	4
Recommendations for antibiotic selection for severe nosocomial infections	4
A systematic review and expert’s analysis of risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain	4
Methicillin-resistant Staphylococcus epidermidis infectious keratitis: Clinical and microbiological profile	4
Tedizolid: new data and experiences for clinical practice	4
Impact of the implementation of a Sepsis Code Program in medical patient management: a cohort study in an Internal Medicine ward	4
Optimized identification of microorganisms directly from positive blood cultures by MALDI-TOF to improve antimicrobial treatment	4
In vitro activity of imipenem/relebactam against Gram-negative clinical isolates in two Spanish tertiary hospitals	4

Utilization study in real clinical practice of ceftolozane/tazobactam vs aminoglycosides and/or colistin in the treatment of multirresistant or extremely resistant Pseudomonas aeruginosa	4
Bioinformatics approaches to the study of antimicrobial resistance	4
The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19	4
Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study	4
Increased severity in SARS-CoV-2 infection of minorities in Spain	4
Increased infections by herpes simplex virus type 1 and polymicrobials of the genital tract, in the general population of a Spanish middle city	4
Etiology of bloodstream infections at a population level during 2013-2017 in the Autonomous Community of Valencia, Spain	4
Latent tuberculosis infection: approach and therapeutic schemes	4
Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria	4
Immune treatment in COVID-19	3
Variability between health areas in antibiotic consumption among pediatric outpatients of Principado de Asturias, Spain (2005-2018)	3
Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program	3
Epidemiology and etiology of vulvovaginal candidiasis in Spanish and immigrants’ women in Fuenlabrada (Madrid)	3
Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient	3
Suppressive antibiotic treatment with dalbavancin. A case report	3
Pelvic inflammatory disease by Streptococcus constellatus. Clinical experience and a review	3
Identification of Brucella melitensis as Ochrobactrum anthropi by MALDI-TOF MS	3
COVID in Pediatric Age: an opinion paper	3
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives	3
Effectiveness, safety, and economic impact of the bictegravir/emtricitabine/tenofovir alafenamide regimen in real clinical practice cohort of HIV-1 infected adult patients	3
Infection control in long term care institutions for the elderly: A reflection document on the situation in Spain	3
Unusual isolation of Pseudoglutamicibacter cumminsii in urine culture	3
Introduction to XI Updating Course of Antimicrobials and Infectious Diseases	3
Implementation of the delayed antibiotic prescribing strategy. Prospective observation study in primary care	3
Prevalence of prescription of the Top-10 drug classes to avoid in elderly people living with HIV in a real practice cohort	3
SARS-CoV-2 screening of asymptomatic women admitted for delivery must be performed with a combination of microbiological techniques: an observational study	3
Pseudocitrobacter anthropi sepsis in a patient with complicated urinary tract infection	3
High-dose trivalent influenza vaccine: safety and immunogenicity	3
Respiratory consequences after COVID-19: outcome and treatment	3
Effectiveness of cell culture-based influenza vaccines compared with egg-based vaccines: What does the literature say?	3
Recurrent ventilator-associated pneumonia caused by “difficult to treat” resistance Pseudomonas aeruginosa	3
Impact of Staphylococcus aureus bacteremia in COVID-19 patients	3
Actions and attitudes on the immunized patients against SARS-CoV-2	3
Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ß-lactamase producing Enterobacterales in patients with diabetic foot infections requiring hospital admission	3
Value of syndromic panels in the management of severe community-acquired pneumonia	3
Necrotizing fasciitis pediatric debut	3
Impact of one year of pandemic on Spanish Intensive Care Units	3
Efficacy of early use of remdesivir: a systematic review of subgroup analysis	3
Mechanism of action of cefiderocol	3
The role of cefiderocol in clinical practice	3
Pseudomonas stutzeri prosthetic joint infection: a therapeutic challenge associated with multiple severe complications	3
Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital	3
Ceftazidime-avibactam	3
Real-world efficacy of switching to bictegravir/ emtricitabine/tenofovir alafenamide in pretreated patients with triple therapy containing rilpivirine	3
Persistence and viability of SARS-CoV-2 in primary infection and reinfections	3
First case of Arcobacter cryaerophilus in paediatric age in Spain	2
Hemophagocytic syndrome in patients infected with the human immunodeficiency virus: A study of 15 consecutive patients	2
New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections	2
Impact of the use of antibiotics on the clinical response to immune checkpoint inhibitors in patients with non-small cell lung cancer	2
Use of clinical vignettes to screen general practitioners who can participate in a clinical trial about stopping antibiotic treatment when this is no longer necessary	2
Listeria monocytogenes, a rare cause of endophthalmitis	2
Evaluation of a lateral flow immunoassay to detect CTX-M extended-spectrum β-lactamases (ESBL) directly from positive blood cultures for its potential use in Antimicrobial Stewardship programs	2
Overview of virus and cancer relationships. Position paper	2
Current treatment of nosocomial pneumonia and ventilator-associated pneumonia	2
Emerging infectious diseases: Streptococcus suis meningitis	2
Reverse transcriptase and protease inhibitors mutational viral load in HIV infected pregnant women with transmitted drug resistance in Argentina	2
Urgent need for a rapid microbiological diagnosis in critically ill pneumonia	2
Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper	2
Microscopy vs. molecular biology in the diagnosis of intestinal protozoal infections, is it time for a change?	2
New evidence in severe pneumonia: meropenem-vaborbactam	2
Usefulness of MALDI-TOF and REP-PCR against PFGE for the epidemiological study of Acinetobacter baumannii	2
Ceftaroline in severe community-acquired pneumonia	2
Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017	2
Dose adjustment of linezolid due to interacction with rifampicin in infective endocarditis	2
Ceftaroline fosamil: clinical experience after 23-month prescription in a tertiary hospital	2
Infections in patients colonized with carbapenem-resistant Gram-negative bacteria in a medium Spanish city	2
Antibacterial spectrum of cefiderocol	2
Ceftolozane-tazobactam in nosocomial pneumonia	2
Antimicrobial resistance and One Health	2
Identifying the most important data for research in the field of infectious diseases: thinking on the basis of artificial intelligence	2
Global strategy in the treatment of HIV infection in 2022	2
Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment	2
Shigellosis attended in the emergency department of a regional hospital in southeastern Spain: from their presence to multiresistance	2
COVID-19 and fungal infections: Etiopathogenesis and therapeutic implications	2
Infective endocarditis treated in a secondary hospital: epidemiological, clinical, microbiological characteristics and prognosis, with special reference to patients transferred to a third level hospit	2
Uncommon adverse events of intravesical Bacillus Calmette-Guérin treatment: A report of three cases	2
Microbial etiology of bacterial chronic prostatitis: systematic review	2
Baricitinib in the treatment of SARS-CoV-2 infection	2
Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting	2
What happened to microbiological diagnosis in 2020 beyond COVID-19?	2

Mycoplasma genitalium in Primary Care: Prevalence and azithromycin resistance in Santiago de Compostela Health Care Area	2
Validity and usefulness of the RAE-CMBD studying patients hospitalised with influenza	2
Update on Bimervax® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553)	2
Infections by OXA-48 carbapenemase-producing Enterobacteriaceae in surgical patients: antibiotic consumption and susceptibility patterns	2
Comparative study of the COVID-19 admissions between first and second wave in a cohort of 1,235 patients	2
Current approach to skin and soft tissue infections. Thinking about continuity of care	2
Report of sexually transmitted infections prevalence in asymptomatic pregnant women under 25 years old in Lleida, Spain	2
Choice of influenza vaccine in people over 65 years old. Analysis of reports from international vaccination advisory committees	2
Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León	2
Management of hyperinflammation in COVID-19 patients	2
Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2	2
Secondary Bordetella hinzii pneumonia in a patient with SARS-CoV-2 infection	2